Industry reports
Editor highlights

Publication dates

Heart Failure Research Reports, April 2014

You might be interested in: medical equipment, chronic heart failure, therapeutics, more »


 

1-10 of 83 reports for Heart Failure
Neurostimulation: Technologies and Global Markets

Neurostimulation: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • March 2014
  • by BCC Research

... Figure 36 : distribution of prevalence of heart failure in males as a percentage of total population according to age group, 2005 to 2008figure 37 : distribution of prevalence of heart failure ...

Stereotaxis, Inc. (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stereotaxis, Inc. (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... Of arrhythmias, heart failure, and coronary artery disease. Through its direct sales force, distributors and sales agents, the company markets its products in the us, europe and other parts of the world ...

Cardiovascular Partnering Terms and Agreements

Cardiovascular Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • March 2014
  • by Currentpartnering

... Cardiomyopathy (heart muscle disease) chest pain congenital heart disease congestive heart failure coronary artery disease ...

Congestive Heart Failure Partnering 2009-2014

Congestive Heart Failure Partnering 2009-2014

  • $ 995
  • Industry report
  • March 2014
  • by Currentpartnering

... This data driven report contains over 25 links to online copies of actual congestive heart failure deals and contract documents as submitted to the securities exchange commission by companies ...

World Therapy: Myocardial Ischemia – Pipeline Review, H1 2012

World Therapy: Myocardial Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... To inhibit trpm7 for cardiovascular disorders and glaucoma - drug profile 52product description 52mechanism of action 52r&d progress 52gene therapy for ischemic heart failure - drug profile 53 ...

World Pathology: Angina (Angina Pectoris) – Pipeline Review, H1 2012

World Pathology: Angina (Angina Pectoris) – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... Tablets) significantly reduced deaths and hospitalizations due to heart failure in investigational study 74oct 11, 2009: procoralan awarded the prix galien 2009 in germany 74appendix 75 ...

Chronic Heart Failure - Pipeline Review, H1 2014

Chronic Heart Failure - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of chronic heart failure- the report reviews key pipeline products under drug profile section which includes, product description, mo ...

CardioPolymers, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CardioPolymers, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Biocompatible polymer implant therapies to treat chronic heart failure, mitral valve regurgitation, and post-operative atrial fibrillation. Its products include algisyl-lvr for the treatment of heart failure ...

ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • February 2014
  • by Global Data

... Respiratory failure (arf), acute respiratory distress syndrome (ards), congestive heart failure with pulmonary edema and neonatal respiratory distress syndrome. Alung is headquartered in pittsburgh ...

AtCor Medical Holdings Limited (Symbol:ACG) SWOT Analysis, Strategy, Revenues and Profits

AtCor Medical Holdings Limited (Symbol:ACG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • February 2014
  • by Global Data

... The company develops products in the areas of hypertension, renal disease, diabetes and heart failure. It works with researchers in australia, europe and the usa to improve the clinical applications ...


» Read our Company Profiles

2 Companies for Heart Failure

Select Products Inc.

United States

Novartis Inc.

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.